Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saxagliptin vs Metformin in Newly Diagnosed Type 2 Diabetes
NCT02920801Phase 4Completed
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Dec 2014
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of saxagliptin in type 2 diabetes mellitus (T2DM), sponsored by Zhongshan Hospital, Fudan University. Started Dec 2014; status: completed.
02
Drugs
saxagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02920801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02920801.